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Abstract 
Objectives This study was undertaken to investigate age-related morphologic and 
functional changes of the zona reticularis (ZR) development in human young adrenal glands. 
Materials and methods Forty-four human autopsy adrenal specimens retrieved from 
large archival files (n=252) were assigned into three age groups according to the gender for 
immunohistochemistry and morphometric analyses. In addition to morphologic observation, 
immunohistochemistry for ZR-specific steroidogenic enzymes was performed to confirm the 
location of the ZR in adrenal cortex, followed by the measurement of the thickness of the ZR, 
the thickness of total cortex respectively and the ratio of ZR thickness to that of total cortex 
(% of the total thickness, R) was also analyzed. Because human adrenal tissue is a cell 
renewal system, the structural homeostasis of developing human adrenals is considered to be 
accomplished by the equilibrium between cell proliferation and apoptosis; I further evaluated 
the immunoreactivity of both Ki67 and Bcl-2 with attempt to elucidate the intra-adrenal 
morphologic changes during ZR development and the cytogenesis of ZR. Adrenal androgen 
synthesizing type 5 17β-hydroxysteroid dehydrogenase (HSD17B5) expression was reported 
in human adrenals and was postulated to play important roles in the biosynthesis of active 
adrenal androgens. Therefore, in this study, the expression profiling of HSD17B5 during 
developing human adrenals was also studied by use of immunohistochemistry to investigate 
its potential significances in human puberty. 
Results The morphologic development of an intact ZR was discernible around 4 years old, 
and both the ZR thickness and its ratio to the total thickness increased in an age-dependent 
fashion thereafter (p<0.01 when compared between 13-20yr and 4-12yr). In contrast, there 
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was no significant increment in total thickness of developing adrenal cortex in both male and 
female adrenals. There were no significant sex differences in the thickness of total cortex, the 
thickness of ZR and the ration of ZR thickness to that of total cortex. Results of the present 
study also demonstrated that the expression of both Ki67 and Bcl-2 showed intra-adrenal 
temporal and spatial dynamics. Proliferative adrenocortical cells were predominantly detected 
in zona glomerulosa (ZG) or partially in outer zona fasciculata (ZF) before 4 years old with a 
higher labeling index (LI) compared with 13-20yr (p<0.05). After 4 years old, the number of 
proliferative cortical parenchymal cells in ZR increased in an age-related fashion but 
markedly decreased near 20 years old. Bcl-2 positive adrenocortical cells were invariably 
observed in the outer ZF and gradually increased in ZR but decreased in ZF with a significant 
inversed correlation in the status of immunoreactivity between ZR and ZF in both male and 
female adrenals (r=-0.827 in male; r=-0.595 in female). HSD17B5 immunoreactivity was 
restricted to the ZR and became discernible and increased from around 9 years old. A positive 
correlation between HSD17B5 immunoreactive ZR and the morphologically determined ZR 
thickness was also demonstrated (r=0.991 in male; r=0.989 in female). 
Conclusions In the present study, I quantitatively demonstrated the development of ZR in 
an age-related manner in young human adrenal glands. In addition, results of the present 
morphologic and chronological analyses support the theory of age-dependent intra-adrenal 
adrenocortical cell migration—bidirectional migration from outer ZF or centripetally 
unidirectional migration from ZG. Our findings suggest that development of ZR is not only 
associated with adrenarche, but may play important roles in the initiation of puberty by 
production of biologically potent adrenal androgens through the expression of HSD17B5. 
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Introduction 
  Human adrenarche is in generally characterized by the appearance of axillary hair, pubarche 
and a transient acceleration of linear growth and bone maturation. Adrenarche has also been 
defined as the increased production of dehydroepiandrosterone (DHEA) and DHEA-sulfate 
(DHEA-S) in human adrenal cortex which occurs between 6 and 8 years old (1). While 
circulating concentrations of DHEA and DHEA-S rise progressively during adrenarche, the 
levels of cortisol and adrenocorticotropic hormone (ACTH) do not change significantly in this 
period, indicating that adrenarche is not simply a global activation of the pituitary-adrenal 
axis but much dependent on intrinsic intra-adrenal changes of steroidogenesis (2). 
It is well known that the human adrenal cortex is composed of three morphologically and 
functionally distinct zones, i.e. zona glomerulosa (ZG), zona fasciculata (ZF) and zona 
retitcularis (ZR) (3). Previous studies have demonstrated that the onset and characteristics of 
adrenarche are also well-known to be associated with alterations in both adrenocortical 
functions and structure (4, 5). The ZR is generally considered the site for DHEA and DHEA-S 
synthesis (6, 7). Therefore, an increment of adrenal androgen production has been considered to 
be closely associated with temporal and spatial changes in the ZR during adrenarche (1, 8). The 
onset of human adrenarche could be attributed to the ZR-specific enzymes favorable to the 
biosynthesis of adrenal androgens. Besides, it is hypothesized that the changes in the 
expression of ZR-specific steroid metabolizing enzymes may be associated with 
morphological development, thus requiring further studies on the morphologic alterations in 
the ZR during adrenarche. Dhom was first to examine the appearance and continuous 
development of ZR in human adrenal glands and suggested that focal islands of the adrenal 
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reticularis cells appear around 3 years old, and the thickness of ZR increase progressively 
until 13 years old and the ratio of the ZR thickness and that of the ZG and the ZF be about 1:1 
when a fully developed ZR is seen in young adults (9). Results of other published 
histomorphologic studies did demonstrate a reduction of the size of histologically identifiable 
ZR with ages but the total cortical width of these adrenal glands remained the same 
throughout the ages, suggesting that ZR regression in elderly population could be responsible 
for the diminished production of DHEA-S, a phenomenon also termed “adrenopause” (10). In 
my current study, I used immunohistochemistry for adrenocortical steroidogenic enzymes in 
order to fully characterize the morphometric and functional changes of the adrenal ZR in both 
males and females from infancy to adolescence.  
As known to us all, adrenal tissue is a cell renewal system in which the adaptive structural 
remodeling is accomplished by a balance between cell proliferation and apoptosis (11). 
However, the cellular dynamics underlying postnatal development of ZR during adrenarche 
has remained unknown. Therefore, I further evaluated alterations of immunoreactivity of Ki67 
and Bcl-2 in human young adrenal cortex during ZR development in order to obtain a better 
understanding of ZR cytogenesis and the dynamics of adrenocortical cells.    
Furthermore, based on the fact that the rise in DHEA-S occurs prior to the increase of either 
estrogens or androgens associated with puberty (12), it has been suggested that adrenarche may 
serve a permissive but not necessary role in the initiation of puberty (13). However, the 
correlation of adrenarche with the initiation of puberty has not been well evaluated. In 
particular, the morphological correlation between adrenarche and puberty remains unknown. 
Taken together, I hypothesized that type 5 17(beta)-hydroxysteroid dehydrogenase (HSD17B5) 
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could be involved in the process of human puberty during ZR development and evaluated the 
pattern of HSD17B5 expression in order to study the relationship between alterations within 
the adrenal during adrenarche and the age of puberty. Results of a recent study did 
demonstrate that HSD17B5, which plays an important role in the conversion of sex steroids in 
periphery-targeted organ, is also expressed in human adrenal gland (14). Usually, HSD17B3 
specifically localizes in the Leydig cells of the testis and provides approximately 50% of the 
total amount of testosterone in men by synthesizing testosterone from androstenedione (15-17). 
However, the same enzymatic reaction is also catalyzed in peripheral target tissues via 
HSD17B5 and HSD17B1, not through HSD17B3.  HSD17B5 has been reported to be most 
abundantly expressed in the human adrenal compared to HSD17B1 and HSD17B3 (18, 19). In 
addition, HSD17B5 was also recently reported to be expressed at higher levels in the adrenal 
ZR using quantitative PCR and immunohistochemistry (20). Therefore, in this study, I also 
evaluated the chronological alterations in the expression of HSD17B5 during ZR 
development of human adrenals using immunohistochemistry. 
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Objectives  
In this study, I focused on the four purposes as followings: 
(1) Besides the morphologic observation, I also used immunohistochemistry to confirm the 
exact location of the human ZR morphologically and functionally.  
 
(2) By morphometry, the age-related changes of the total thickness, the thickness of ZR as 
well as the ratio of the ZR thickness to that of the total thickness in postnatal human young 
adrenal glands were analyzed with attempt to obtain a better understanding of both the timing 
of the onset of continuous morphologic ZR and the potential effects of the ZR development in 
an age-related manner on the whole adrenal cortex; Besides, sex dimorphism during ZR 
development was also discussed. 
 
(3) The functional ZR development has long been an enigma. As a cell renewal system, 
normal adrenal cortex is structurally dependent on the well-balanced homeostasis. It is 
worthwhile to investigate the cytogenesis of the ZR and its possible effects on the whole 
adrenal cortex. In addition, traditional theories of adrenal zonation were also included to 
provide additional evidences.  
 
(4) Besides the adrenarche, the issue on whether or how the ZR development will play roles 
in human puberty was also extended in this study with aim to give possible suggestions on the 
potential relationship between human adrenarche and puberty. 
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Materials & Methods 
1. Tissues and Age groups 
  Human adrenal autopsy specimens from birth to adolescence (n=252, from postnatal 7 
months to 20 years old) were retrieved from autopsy files of Tohoku University Hospital 
(n=224) and National Hospital Organization Sendai Medical Center (n=28), Sendai, Japan 
from 1990-2007 respectively. Forty-four specimens were selected for study from this large 
group of archival tissue specimens following careful histological or morphologic screening 
from the standpoints of the following four inclusive criteria. Firstly, the postmortem time was 
less than 3 hours for all specimens followed by immediate tissue collection, and then were 
fixed in 10% neutral formalin solution and embedded in paraffin within 24 hours. Secondly, it 
was assured that all subjects had not received any forms of adrenocortical steroids or suffered 
from chronic illness prior to their demise. Review of these case records revealed that most of 
them died of congenital cardiovascular malformation or traffic accidents, 2 cases died of 
congenital biliary atresia and esophageal atresia respectively, and 2 cases were attributed to 
sudden infant death syndrome (SIDS). Thirdly, histological examination showed no 
significant pathological abnormalities including nodules or neoplasms. Lastly, all these 
adrenal specimens contained full thickness extending from capsule to medulla. The 
paraffin-embedded specimens were sliced into 3µm thickness tissue sections and prepared for 
immunohistochemistry. 
  Based on the results in the preliminary experiment, these involved specimens were assigned 
into three age groups after gender stratification: Group 0-3 years old (n=5 in male; n=4 in 
female); Group 4-12 years old (n=8 in male; n=5 in female); Group 13-20 years old (n=12 in 
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male; n=10 in female). This protocol was approved by Institutional Review Board of Tohoku 
University School of Medicine, Sendai, Japan (2004-355) and National Hospital Organization 
Sendai Medical Center. 
 
2. Antibodies 
  In Experiment one, the polyclonal antibodies for steroid-sulfotransferase type 2A1 
(SULT2A1) and 3β-hydroxysteroid dehydrogenase (3βHSD) employed in this study were 
generated in goat and rabbit, respectively. Optimal dilutions of both primary antibodies were 
1:1000 for antibody SULT2A1 and 1:2500 for antibody 3βHSD. In Experiment two, antibody 
for Ki67 or MIB1 , a nuclear protein generally considered  a marker of cell proliferation; 
antibody for Bcl-2, one of important factors involved in cell apoptosis; antibody for 
HSD17B5, a member of aldo-keto reductase superfamily (also called AKR1C3) with the 
ability to convert androstendione to testosterone; these three antibodies were 
immunohistochemically analyzed. The antibody for HSD17B5 was kindly provided from Dr 
Yasuhiro Nakamura (Department of physiology, Medical College of Georgia, Augusta, GA). 
The detailed information of antibodies was summarized in Table 1. 
 
3. Immnohistochemistry 
  Immunohistochemical analyses were performed by the streptavidin-biotin amplification 
method using a Histofine Kit (Nichirei, Tokyo, Japan). Briefly, after deparaffinization, 
sections were treated with 0.3% hydrogen peroxidase in methanol for 30 min at room 
temperature to quench endogenous peroxidase activity and then treated with 1% normal rabbit 
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or goat (when the primary antibody was raised by rabbit) serum for 30 min at room 
temperature in a moisture chamber. The sections for Ki67 and Bcl-2 immunostaining were 
immersed in citric acid buffer (0.002 M citric acid and 0.009 M trisodium citrate dehydrate, 
PH 6.0) and heated in autoclave for 5 min at 1270C and were subsequently allowed to cool for 
approximately 1 h at room temperature for antigen retrieval. The diluted primary antibodies 
were incubated with sections for at least 18 h at 40C. After rinsing in 0.01 M 
phosphate-buffered saline (PBS), sections were incubated with the biotinylated second 
antibodies for 30 min at room temperature, followed by exposure to peroxidase-conjugated 
streptavidin for 30 min at room temperature. The antigen-antibody complex was visualized by 
immersing these sections in chromogen 3,3’-diaminobenzidine (DAB) solution (0.001M DAB, 
0.05M tris-HCL buffer, PH 7.6, 0.01M sodium azide, and 0.006% hydrogen peroxidase). The 
nuclei were counterstained with hematoxylin. As a negative control, the primary antibodies 
were omitted and replaced with normal rabbit serum. No specific immunoreactivity was 
detected in these sections.  
  The immunohistochemical procedures were performed by the same technician as carefully 
as possible under the same conditions among all slides. Besides, the procedures were repeated 
at least three times for each antibody.   
 
4. Experiment One 
4.1 The instructions of quantitative measurement of adrenal cortex 
4.1.1. Scale definition  
By use of the microscope-attached computerized image capture and analysis system 
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(Penguin/Pro 600ES Pixel Digital Camera System, USA), a standard micrograph was 
prepared as a measurement scale under 4x light microscope objective. The minimum unit was 
10µm and the final values could be expressed by micrometers, which was much more 
accurate and understandable than the arbitrary units such as pixels used by previous studies (10) 
(Fig.1). 
 
4.1.2. Immunohistochemistry for SULT2A1 and 3βHSD 
It is important to exactly distinguish ZR from the adjacent ZF before performing 
measurement. Besides, because it is difficult or subjective to identify the ZR by use of 
hematoxylin and eosin (H/E) staining only, I performed immunohistochemistry for SULT2A1, 
the enzyme responsible for the sulfonation of adrenally derived DHEA that is nearly 
exclusively localized in the ZR of human adrenal cortex (21, 22). Furthermore, in order to 
clarify the border between ZF and ZR, I also employed immunohistochemistry for 3βHSD for 
tissue sections obtained from the subjects with older than 8 years old when the 
immunoreactivity of 3βHSD has been demonstrated to be significantly weaker in the ZR than 
in the ZF (23). In addition, Dardis et al. reported a decrement of mRNA levels of 3βHSD in 
adrenals from children age 8 years and older compared to children younger than 8 years old 
(24). The combined use of immunohistochemistry for both SULT2A1 and 3βHSD allowed 
accurate localization and measurement of ZR for specimens obtained from the subjects with 
older than 8 years old. Because the ZR in the sections between 4 and 8 years old was 
demonstrated to be clearly identified by SULT2A1 solely, no immunohistochemistry for 
3βHSD was supplemented in these sections.   
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4.1.3. Micrograph 
  By the same computer-attached light microscope under 4x microscope objective, the slides 
processed for SULT2A1 and 3βHSD immunohistochemistry were carefully observed and then 
captured under the same conditions as the scale. Digital images of each section including five 
quadrangle-shaped visual fields were prepared. I did not emphases the random selection of 
visual field due to the irregularity of adrenal gland, but highly valued the importance of 
selecting the regular and intact cortical regions favourable to measurement. For this purpose, 
the cortex was defined as those cells laying between the medulla and the adrenal capsule; 
areas in which medullar veins and their associated cortical cuff cells as well as the cortical 
curves were excluded from quantitative analysis due to the complexity of the cortex in such 
regions.  
 
4.1.4. Measurement 
  The image–edited software (Adobe Photoshop Elements 5.0, USA) was used to modify 
these captured micrographs. In detail, a straight line was drawn from the subcapsular area of 
the adrenal cortex to the edge of medulla inward in the direction of cord-like ZF, followed by 
drawing another parallel line representative of the thickness of ZR. After these two straight 
lines were copied to the scale micrograph respectively, their lengths were determined 
accurately by expression of micrometers (Fig.2). Finally, five values were measured for each 
section and the average value was determined for final analysis. All of the measurements were 
conducted in the blind fashion or without the knowledge of the age and sex of the donors. The 
data collected in these analyses included the total cortical thickness, the thickness of ZR and 
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the ratio of the thickness of ZR to that of the total cortex expressed by % (R). 
 
4.2 Statistical analysis 
All data were expressed as mean± standard deviation (SD). For analyses of different age 
groups, I performed one-way analysis of variance (ANOVA) followed by Bonfferoni t test for 
comparison between two groups. For the comparison of sex difference, I used Student’s t test. 
A P value of less than 0.05 was considered significant. All above analyses were performed by 
use of SPSS software (SPSS 11.0, Chicago). 
 
5. Experiment Two 
5.1. Immunohistochemistry for Ki67, Bcl-2, and HSD17B5 
  The unstained sections employed in Experiment one were then examined by 
immunohistochemistry for Ki67, Bcl-2, and HSD17B5 with the same procedures, which have 
been described in the part of Materials & Methods. 
 
5.2. Evaluation of immunoreactivity of Ki67 and Bcl-2 
  It is well-known that quantification of immunoreactivity is difficult due to the influence of 
various factors. In the present study, different methods were used to assess immunoreactivity 
of the antibodies employed in Experiment two according to their characteristics of expression 
in human adrenals. The immunoreativity of Ki67 was evaluated quantitatively by labelling 
index (LI) which represented the number of positive cells per 1000 adrenocortical cells. In 
detail, before counting, the areas for the analysis were designated by two pathologists (Suzuki 
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T and Akahira J) using a double-headed light microscope. For each section, 5 to 10 high 
power fields (40x light microscopic objective) were selected, and at least 1000 cells were 
independently counted by the two pathologists. The tissue sections with interobserver 
differences greater than 5% were revaluated. I calculated the mean values only in the 
specimens with interobserver differences of less than 5%.  
With respect to the Bcl-2, I found that the positive cells were characterized by the 
zone-based distribution with ages meaning that adrenal cortical cells were either totally 
expressed or detected with different scales in a certain zone. Therefore, based on the modified 
previously published literature (25), we decided the following semiquantitative analysis by 
estimating the percentile of positive cells. In brief, the most immunointensitive region (76 to 
100%) was given an arbitrary ranking of 5 and the medulla, which was negative, was 
designated 0 (equal to <1%), and a scoring 1 to 4 corresponded to 1-10%, 11-30%, 31-50%, 
51-75%, respectively. Histological identification of the three zones of the adrenal cortex was 
based on that of previously published description (26). Specifically, the glomerulosa was 
identified as discontinuous subcapsular aggregates of small cells nuclei and few lipid droplets. 
The fasciculata was identified as the large, lipid-laden cells arranging in a cord-like pattern. 
The reticularis was identified by the lack of cord-like organization and the compact, 
lipid-poor nature of the cells. The immunoreactivity for each zone was determined by blind 
ranking of each section by two observers above, and numerical values from each observer 
were then averaged.  
The values were expressed as mean±SD, and they were treated by nonparametric data. I 
statistically analyzed overall comparison of Ki67 by one-way analysis of variance, followed 
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by the Kruskal-Wallis rank sum test, and the Bonferroni method for comparisons between two 
groups. For the statistical analysis of Bcl-2, I compared the immunoreactivity between the ZR 
and the ZF with the same age group by analysis of Wilcoxon’s rank sum test. Spearman 
correlation coefficients (r) were calculated to evaluate the correlation of immnoreactivity 
between the ZR and the ZF. Significant difference was accepted at p<0.05. All above analyses 
were performed by use of SPSS software (SPSS 11.0, Chicago).  
 
5.3. Analysis of immunoreactivity of HSD17B5 
  It has been reported that the expression of HSD17B5 is restricted to the ZR in human 
adrenal cortex (20, 27). The quantitative evaluation of immunoreactivity was performed by 
measuring the thickness of HSD17B5 immunoreactive ZR using the same measurement 
described in Experiment one. The identical areas for both measurements were designated in 
advance. The correlation between the thickness of HSD17B5 immunoreactive ZR and that of 
established ZR above was estimated by spearman correlation coefficient (r).  
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 Results 
1. Adrenal cortex total thickness 
  In male adrenal cortex, the total thickness (µm) in 0-3 years old group (512.00±49.19) was 
significantly less than that in two older groups examined (p<0.01), whereas there was no 
significant difference between older groups 4-12 years old (846.75±222.43) and 13-20 years 
old (956±185.21) (Fig.3A). The total thickness in male displayed a sharp increase from 4 
years old until 12 years old followed by somewhat fluctuation but reached plateau in 13-20 
years old group (data not shown).  
In female adrenal cortex, no significant difference was detected between 0-3 years old 
(669.25±160.46) and 4-12 years old group (865.20±221.48); However, the size of cortex in 
adrenals from 13-20 years old group (1063.60±155.74) were significantly larger than 0-3 
years old group (p<0.01) but not in 4-12 years old group (Fig.3B). There was also no 
significant difference between two older groups as shown in male. By contrast with males, a 
superior growth in 0-3 years old group was observed and the plateau reached around 16 or 17 
years old in female (data not shown). 
 
2. The thickness of the ZR 
  The morphologically intact ZR was not discernible in adrenals younger than 3 years old. 
Therefore, the thickness of the ZR in 0-3 years old group was recorded as zero in both male 
and female adrenals. Starting from around 4 years old, the innermost intact ZR became 
morphologically discernible and displayed a progressive increment with ages. The thickness 
of the ZR in 13-20 years old group was significantly greater than that in 4-12 years old group 
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in both male and female adrenals (p<0.01). In detail, the thickness (µm) in 4-12 years old 
group was 185.25±77.80 in male and 243.00±69.89 in female; the thickness (µm) in 13-20 
years old group was 356.17±125.26 in male and 405.00±126.31 in female (Fig.4).  
 
3. The ratio of the thickness of ZR to that of the total cortex (R) 
  Due to the absence of morphologic development of the ZR, the R value in 0-3 years old 
group was also recorded as zero in both male and female adrenals. For adrenals from subjects 
older than 4 years old, the R value (ZR % of total cortical thickness) exhibited a progressive 
increment. In detail, the value (%) in male was 21.34±4.49 in 4-12 years old group and was 
35.86±7.12 in 13-20 years old group, which showed the significant difference (p<0.01). The 
difference was also significant between 4-12 years old group (27.81±4.14) and 13-20 years 
old group (37.83±7.18) in female adrenals (p<0.01). The R value increased to above 50% 
around 16-17 years old in female but not in male adrenals (Fig.5). 
 
4. Sex comparison 
There were no significant differences in the total adrenal thickness among any one of three 
age groups between male and female adrenals (p>0.05). In addition, neither 4-12 years old 
nor 13-20 years old adrenals demonstrated significant sex differences in the thickness of the 
ZR and the R values (p>0.05). 
 
5. Immunohistochemistry for Ki67 
  Ki67/MIB1, as a proliferative marker, has been well known to play a fundamental role in 
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cell proliferation, and also be correlated well with mitotic count and other indices of cell 
proliferation in the human adrenal (28, 29). Therefore, I chose Ki67 as an immunohistochemical 
marker of cell proliferation in the present study. Ki67 immunoreactivity was detected only in 
nuclei of adrenorcortical cells but not in those of the capsule and medulla. In male adrenals, 
the immunoreactivity in 0-3 years old group was focally present in ZG with the highest LI (%) 
of 6.6 at age 8 months and the average LI was 5.22±1.19; Intriguingly, Ki67 positive cells 
were observed in ZR at 4 years old and its number went onto peak at 12 years old with the LI 
of 13.0 in ZR. The average Ki67 LI in 4-12 years old group was 5.63±3.40; However, the 
immunoreactivity of adrenocortical parenchymal cells in the ZR progressively declined in 
specimens approaching to around 20 years old but the lymphocytes or macrophages could be 
observed in the sinusoid of the ZR in some of adrenal sections, and the average LI 
accordingly dropped to 2.64±1.50 in 13-20 years old group. Regardless of its intra-adrenal 
distribution of immunoreactivity, Ki67 LI was significantly higher in 4-12 years old group 
than that in 13-20 years old group (p<0.05). The age-related changes of Ki67 
immunoreactivity in male were illustrated in Fig.6. 
In female adrenals, immunoreactivity in specimens younger than 4 years old was also 
mainly located in the ZG or sometimes in the outer ZF with the LI (%) of 7.05±3.10 in 0-3 
years old group and the highest LI of 10.2 was detected at age 7 months. However, the Ki67 
positive adrenocortical cells were also present in ZF before becoming discernible in ZR 
around 4 or 5 years old and then increased later in ZR. The highest Ki67 LI of 11.5 was 
detected predominately in the inner ZR and partly in ZF around 15 years old followed by 
progressive decline toward 20 years old (LI in 4-12 years old group was 2.50±1.44; LI in 
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13-20 years old group was 4.28±3.62). Likewise, the lymphocytes or macrophages in the 
sinusoid could also be discernible in the ZR in adrenal specimens near 20 years old. The 
age-related changes of Ki67 immunoreactivity in female were summarized in Fig.7. The 
levels of Ki67 LI in these three age groups were summarized in Table 2. 
 
6. Immunohistochemistry for Bcl-2 
  Bcl-2 expression is a cellular mechanism to prevent apoptosis. Previous studies reported 
that Bcl-2 is expressed in normal human adrenal cortex (30). In my present study, 
immunoreactivity of Bcl-2 was demonstrated in the cytoplasm of adrenal cortical cells but not 
in the capsule or medulla. The age-related changes of Bcl-2 immunoreactivity in both male 
and female adrenals were summarized in Table 3. Briefly, before 4 years old, relatively lower 
level of Bcl-2 immunoreactivity was detected in the adrenal cortex (it was recorded as 0 due 
to the absence of the ZR). After around 4 years old, Bcl-2 positive cells frequently appeared in 
the ZF, especially in the outer part of this zone. In addition, Bcl-2 immunoreactivity in ZF, 
mainly in the inner ZF adjacent to the ZR, decreased while it increased in the ZR with ages 
(Fig.8). I did not find any differences in staining characteristics between the distinct layers of 
the adrenal cortex except for some individual adrenal cortical cells with densely 
immunostained products standing out on the homogeneous background. Moreover, Bcl-2 
immunoreactivity was significantly higher in ZF in 4-12 years old group but higher in ZR in 
13-20 years old group (Fig.9, A and B). The inversed correlation of immunoreactivity 
between ZF and ZR was also demonstrated in both male and female adrenals (r=-0.827, 
p<0.01 in male; r=-0.595, p<0.05 in female; Fig.9, C and D). 
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7. Immunohistochemistry for HSD17B5 
  HSD17B5 immunoreactivity was predominantly detected in the cytoplasm of ZR but not in 
the medulla or the other cortical zones. As a negative control, no staining was observed in the 
absence of antibody HSD17B5. In both male and female adrenals, immunoreactivity of 
HSD17B5 in ZR was not easily discernible until approximately 9 years old, later than the 
onset of a continuous ZR development which started around 4 years old (Fig.10). In addition, 
by measuring the thickness of HSD17B5 immunoreactive ZR, there was an age-related 
increase in the thickness of specimens older than 9 years of age. An analysis using spearman 
correlation demonstrated a significantly positive correlation between the morphologically 
determined thickness of the ZR and that of HSD17B5 immunoreactive ZR in both male and 
female adrenals (r=0.991, p<0.01 in male; r=0.989, p<0.01 in female; Fig.11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
23 
 
Discussion 
  Adrenal DHEA-S secretion demonstrates a unique age-dependent pattern during the human 
life span (Fig.12). Before birth, DHEA-S rises progressively to reach a peak at term and 
followed by precipitous decline during the first months of life and remains low until 
adrenarche commences at about ages 6-8 years old (1). Circulating concentration of DHEA and 
DHEA-S continues to rise and reach its peak during the second decade of life (31). The 
production of DHEA-S is so enormous during certain periods of our life span that DHEA-S is 
quantitatively the most abundant steroid hormone secreted by human adrenal. A previous 
study demonstrated that DHEA-S level was higher in the first day of life in both sex than 
those of normal adults, suggesting that the high values observed in the first month of life 
could correspond to the relatively high adrenal weight compared to the birth weight (BW) 
observed at delivery (0.38±0.33%), which decreases thereafter until the first year of age 
(0.13% of the BW). They also suggested that this pattern of DHEA-S level could be related to 
the involution of the fetal zone of the adrenal cortex because the width of the fetal zone was 
83±16% of the total cortex in the first day after delivery, while after the second day, the fetal 
zone constituted 19% of the total cortex in infants one or two years of age. During childhood, 
the general pattern of DHEA-S in boys and girls is characterized by a rapid decline from 2 to 
6 years of age, and at the age of 6 years, DHEA-S level rises in both sex but was sharper in 
girls than in boys; during puberty, it increases progressively and correlates well with pubertal 
stages. The higher values observed in girls than in boys were not significant in their studies 
(32).  
Within the adrenal, the thickness of the ZR has been generally postulated to correspond to 
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the increased production of DHEA and DHEA-S (9, 33) (Fig.13). In childhood, there is no 
innermost zone during the period of involution of fetal zone after about one month old, and a 
morphologically distinct ZR has formed by adrenarche when synthesis of adrenal androgens 
begins again followed by full development in young adulthood after 20 years of age, the same 
point in the life span at which synthesis of adrenal androgens reaches its maximum (34). The 
ZR has the appropriate enzymatic machinery required for DHEA-S biosynthesis such as the 
low expression of 3βHSD and the high activity of SULT2A1 (7). It is, however, nearly 
impossible to correlate the increment in individual DHEA-S levels during adrenarche with 
corresponding morphology of the ZR even employing sophisticated image analyses, and the 
functional development of the ZR has not been reported at all in previous literatures. 
Therefore, in my present study, I quantitatively and chronologically examined ZR 
development in human young adrenals using autopsy materials. Results of the study 
demonstrated the following: 1) The total thickness of male adrenal cortex was significantly 
greater in older age groups, possibly due to the near absence of the adrenal ZR in younger 
adrenals. After 4 years old, the expansion of the ZR started but did not result in a significant 
increment in total thickness of the cortex, suggesting that the early stages of adrenarche relate 
to intra-adrenal remodelling through a loss of cortical cells other than ZR or the direct 
transformation of ZF to ZR cells; 2) I also demonstrated subtle differences for age-related 
progressive development of the ZR in both male and female adrenals. Classically, human 
adrenarche was postulated to start between 6 and 8 years old. Dhom suggested that a 
continuous ZR started to be seen around 6 years old, which is different from 4 years old 
suggested in this study. Dhom also emphasized that the important structural change is 
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characterized by a gradual dissolution of medullar capsule and equally slow subsequent 
development of the ZR (9). Coincidentally, I also observed the breakdown of medullar capsule 
together with the first appearance of aggregations of reticular cells at 3 years old in my 
present study (Fig.14). Before 4 years old, only islet-like pockets of reticular cells could be 
seen in the innermost cortex. However, results of my study are similar to more recent studies 
(15, 35) suggesting the morphologic onset of ZR probably occur around 4 years old. This 
discrepancy may be related to employment of immunohistochemistry to localize the ZR in 
addition to histological recognition in the later studies. Results of my study which clearly 
demonstrated the morphologic appearance of functional ZR before 6 years old are also in 
agreement with the reports by Remer and co-workers (36) showing earlier detection of urinary 
adrenal androgens. Results of these morphologic and steroid studies all suggest that the 
gradual onset of adrenarche does start earlier than previously postulated. The late onset of 
clinical adrenarche characteristics may be interpreted by the earlier morphologic and 
functional development of the ZR for the accumulation of sufficient adrenal androgens, but 
further investigations are required for clarification. The early phase of morphologic 
development of human adrenal ZR was illustrated in Fig.14.  
In the present study, I also demonstrated subtle sex difference for the age-related 
progressive development of the ZR. Before the onset of ZR development, the total adrenal 
cortex in female was thicker than that of males with the earlier years of life. Following the 
onset of puberty, both the total width and the ZR thickness of female adrenals exhibited a 
faster development than in male adrenals. In particular, the ratio of ZR thickness of the female 
adrenal around 16 or 17 years old in the 13-20 years old group surpassed 50% of the total 
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cortex suggestive of remarkable development or remodelling particularly in female adrenals 
though there were no significant gender differences in total cortex thickness during this period 
of development. DePeretti E et al demonstrated a trend for higher levels of circulating DHEA 
in girls than in boys from ages 6-10 years old but the differences did not reach significance (1). 
Based on the present data, I could not draw a conclusion of sex difference although female 
adrenals showed a sharp development of ZR. The further analyses on sex dimorphism are 
warranted.  
In Experiment two, I examined the changes of adrenocortical cells in proliferation and 
apoptosis with an attempt to elucidate the cytogenesis of ZR. Ki67 has been well employed to 
evaluate cell proliferation in the human adrenals. The temporal and spatial intra-adrenal 
patterns of Ki67 positive adrenocortical cells are not only consistent with a putative 
characteristic of centripetal migration, but with the hypothesis that the multipotential 
progenitor cells may exist in the outer ZF or ZG in human adrenal cortex. Moreover, 
lymphocytes and macrophages became discernible in the sinusoid in human adrenals near 20 
years old and Ki67 LI in the adrenocortical parenchymal cells accordingly declined in these 
age groups suggesting that the apoptotic ZR cells were probably removed by phagocytosis, 
which consequently provides space for the centripetal replacement of ZR cells. Macrophages 
are detected in the inner zone and belong to the phagocytotic compartment characterized by 
the expression of KiM8 and the adhesion molecules CD68 (37). They may serve as the 
scavengers of the apoptotic remnants in the inner cortical layer which may start to occur in 
abundance after 20 years old. Referring to sex difference in LI of Ki67 immunoreactivity, I try 
to suggest that the stronger and later capacity of proliferation in female could partly explain 
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the superior growth of adrenal cortex in female than male adrenals. 
  Bcl-2 is involved in apoptosis because it encodes for proteins that inhibit apoptosis, thus 
prolonging the survival of cell populations (38). Results of my present study demonstrated that 
Bcl-2 expression was frequently detected in the outer ZF and inversely associated with its 
expression in ZR. Therefore, the outer ZF may actively inhibit apoptosis and maintenance of 
the ZR may be achieved by allowing apoptosis or the functional conversion of ZR cells at the 
inner ZF cells or reticularis/fasciculata border, and this also elucidated the unchanged total 
thickness in this study. Parker also demonstrated that after adrenocorticotropic hormone 
(ACTH) treatment the lipid-poor compact ZR widens, sometimes sufficiently to encroach on 
the adjacent lipid-rich ZF cells (4). However, it is also important to note that negative 
expression of Bcl-2 does not necessarily represent the presence of apoptosis as terminal 
deoxynycleotidyotransferase-mediated dUTP nick end labelling (TUNEL) assay. TUNEL 
assay could not be performed in my series because the nature of the materials obtained from 
autopsy. Therefore, it awaits further investigations for clarification.   
  Results of Ki67 and Bcl-2 in developing human adrenals in my present study are consistent 
with classical theory of zonation driven by cell migration in human adrenal glands, which was 
also proposed by Sasano H et al (29). In the migration model, each zone is derived from a 
common pool of progenitor cells located in the periphery of the cortex, which then migrate 
inward and differentiate to populate the inner cortical zones (39, 40). This model implies that all 
cortical cells have a common origin and that their phenotype changes according to their 
location within the cortex. It is likely, therefore, that cells proliferate in periphery of the cortex 
and subsequently migrate centripetally (by active migration or passive mitotic pressure). 
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During their inward migration, they may differentiate to form the specific cortical zones only 
to undergo senescence when they reach the centre of the gland followed by their loss from the 
system following apoptosis. It is well established that cells from different zones just represent 
distinct phenotypes of a single cell type named adrenocyte. The adult adrenal cortex 
undergoes permanent regeneration and maintenance of normal adrenocortical size involves 
cell proliferation in the ZG, subsequent centripetal displacement and differentiation in the 
fasciculata and cell deletion through apoptosis in the deep fasciculate and reticularis zones (41). 
Subcapsular remnants obtained after adrenal enucleation are able to regenerate a differentiated 
cortical tissue with functional ZF and ZR, even when grafted in ectopic locations (42). Result 
of my present study also confirmed that proliferative adrenocortical cells invariably exist in 
the outer cortex before 4 years old followed by abundant expression in ZR during human 
pubertal ages. The centripetal stream of proliferative parenchymal cells through the 
development may contribute to the expansion of ZR. Meanwhile, the outmost ZF was 
considered as the anti-apoptotic region, and the decline of Bcl-2 expression in the innermost 
ZF as well as the increase in ZR with ages implicated that the transformation or regression of 
inner ZF cells could contribute to the development of ZR. Therefore, Bcl-2 is also a key factor 
regulating the chronological distribution of adrenorcotical cells within cortex by controlling 
apoptosis. The balance between Ki67 and Bcl-2 is also considered as one of key regulatory 
factor controlling the development and maturation of ZR in human adrenal glands.  
The onset of puberty overlaps with adrenarche and ZR development, but the correlation 
between two processes is unclear. Adrenarche has been hypothesized to have an effect on 
gonadotropin-releasing hormone (GnRH) secretion and the pubertal process because of the 
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increase in adrenal androgen biosynthesis that occurs prior to puberty (12). However, 
DHEA/DHEA-S are relatively poor regulators of the androgen receptor and their influence on 
the hypothalamus is not clear. Testosterone, active androgen, is known to be mainly produced 
in the male testis or female ovary controlled by luteinizing hormone (LH) from pituitary (15). 
In addition, it is also reported that a small amount of testosterone may also be synthesized in 
the human adrenal gland (43). However, the expression and potential functions of HSD17B5 
are not well studied. Very recently, Nakamura et al demonstrated that ZR cells express 
HSD17B5 in human adult adrenals and confirmed that ACTH administration increased serum 
testosterone levels in female adrenal vein samples suggesting that HSD17B5 in ZR play an 
important role in the production of testosterone in the human female adrenal (27). The 
production of more potent androgens, even in low levels during the course of adrenarche, 
could provide a new link between adrenarche and puberty. Such androgens would also be 
more likely to control the process of pubarche, which is considered to occur as a result of 
adrenarche. In the present study, HSD17B5 was predominantly detected in the ZR of human 
young adrenals around 9 years old when puberty is considered to be initiated. Therefore, we 
suggest that HSD17B5 may be involved in the onset of puberty by the production of more 
active androgens. In addition, some boys with poor adrenal androgen suppression due to 
undertreated congenital adrenal hyperplasia developed true precocious puberty (44). This 
would imply that increased concentrations of adrenal androgens may enhance gonadotropin 
secretion in children. Adrenarcheal secretion of androgens has also been postulated to cause 
the observed developmental decrease in circulating concentrations of sex hormone-binding 
globulin (SHBG) seen in normal boys and, thereby, accelerate the pubertal process by the 
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augmentation of biologically available testosterone concentration (45). Therefore, it was 
postulated that pathologically increased adrenal androgen concentrations may cause 
precocious puberty, and physiologic levels may be permissive but do not appear to be 
sufficient to induce pubertal development by itself. In this study, I try to suggest that 
HSD17B5 is reasonably considered to play very important roles in connecting between 
adrenarche and puberty through providing more active androgens during ZR development. 
While the present results could not necessarily demonstrate a definitive relationship between 
puberty and ZR development in human developing adrenal glands, results of my present study 
could certainly provide further support for the temporal association of these two processes. 
Besides the effect of puberty, other potential biological roles of adrenal androgens could be 
implicated in immunocompetence, neurologic function and tumour inhibition and so on, 
which may be eventually related to the ZR-dependent adrenarche (46, 47).  
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Conclusions 
First, I have described in detail the age-related quantitative changes in the thickness of total 
cortex and the ZR during developing human adrenals, and demonstrated that the 
age-dependent continuous ZR development did not bring about the remarkable alterations in 
the thickness of total cortex suggestive of the morphologic maintenance of adrenal cortex 
through intrinsic intra-adrenal self-remodelling in human young adrenals. 
 
Second, I demonstrated that the morphologically discernible development of the ZR 
initiates at 4 years old, which possibly provides the new insights that the gradual onset of 
adrenarche starts earlier than previously postulated timing of between 6 and 8 years old. The 
potential significance of the prior appearance of intact ZR could be beneficial for producing 
enough DHEA and DHEA-S to induce the late-onset clinical manifestations related to 
adrenarche. 
 
Third, by the combined analysis of both proliferation and apoptosis, I provided additional 
evidences advocating the classical theory of centripetal migration. Age-related centripetal 
flow of proliferating adrenocoritcal cells (possible cortical stem cells called adrenocyte) 
probably could exist in the periphery of adrenal cortex, and they differentiated and matured 
into the reticularis cells in the innermost area leading to the full development of the ZR 
around 20 years old. Meanwhile, in the process of the ZR development, the adjacent ZF cells 
shrank facilitating the progressive expansion of the ZR through the possible apoptosis or 
direct transformation into ZR cells. 
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Certainly, the above conclusions summarized in the present study are necessary to be 
further investigated due to the employed autopsy materials and the small number of 
specimens. Some issues are not conclusive, or some results could not be well clarified. 
Therefore, the sex difference, the apoptosis of adrenocortical cells, and so on also required to 
be investigated in the coming studies.  
 
The most interesting project in the near future may be focused on the isolation and location 
of so called progenitor adrenocortical cells and make clear the theory of migration. The ZR 
development and possible physiological roles are also necessary to be extensively 
investigated.    
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Tables 
 
Table 1 List of antibodies for immunohistochemistry in this study 
AC, autoclave; ZR, zona reticularis; ZF, zona fasciculata; ZG, zona glomerulosa 
 
 
 
                Table 2 Labeling index of Ki67 among age groups 
Labeling Index (%) 
Ages (cases of specimens M/F)       
Male (M)          Female (F) 
         0-3 yr  (5/4)               5.22±1.19a         7.05±3.10a      
       4-12 yr  (8/5)               5.63±3.40ab        2.50±1.44a         
      13-20 yr  (12/10)             2.64±1.50         4.68±3.62        
Immunoreactivity of Ki67 was quantitatively evaluated by labeling index and expressed by  
mean±SD, followed by statistical analysis.  a p<0.05 vs. Group 13-20 years old within the  
same gender by Kruskal-Wallis rank-sum test;  b p<0.05 vs. Group 4-12 yr in female by  
Wilcoxon rank sum test. 
 
 
 
 
 
 
 
 
Antibody    Animal   Pretreatment  Dilution    Specificity     Source 
                 SULT2A1       goat         ─         1:1000        ZR           Santa Cruz      
 Experiment One                                                                       
                 3βHSD         rabbit        ─         1:2500     ZG and ZF (>8yr)   Dako 
                 Ki67 (MIB-1)    mouse      AC         1:100        Nucleus         Dako 
Experiment Two     Bcl-2       mouse     AC         1:80         Cytoplasm       Dako        
                 HSD17B5       mouse       ─         1:200       Cytoplasm in ZR   Sigma 
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     Table 3 Summary of relative expression of Bcl-2 in developing human adrenals 
Age group (cases) 
 Zona Glomerulosa      Zona Fasciculata        Zona Reticularis 
  M         F         M         F          M         F 
0-3 yr  (n=9)    0.4±0.22  1.5±0.58   1.8±0.50   0.5±0.11   0.0±0.00   0.0±0.00     
4-12 yr  (n=13)   0.5±0.21  0.6±0.34   3.3±0.60a   3.0±0.44b    2.0±0.83   1.5±0.54     
13-20 yr  (n=22)   0.8±0.45  0.8±0.62   1.4±0.55a   1.5±0.62b    4.6±0.43   4.3±0.71     
Immunoreactivity of Bcl-2 in three zones of human young adrenals. Arbitrary units: 5 (highest degree of  
staining) to 0 (negative staining). Data are expressed as mean±SD. Zona Reticularis was compared  
with Zona Fasciculata within each age group. a p<0.05 vs. Zona Reticularis in male adrenals;  
b p<0.05 vs. Zona Reticularis in female adrenals; M, male; F, female 
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Fig.12 
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Figure legend 
 
Fig.1 The micrograph representing measurement scale with 10µm minimum unit (under 
4x light microscopy object). The original scale was captured and the digital image was created 
as measurement scale by use of microscope-attached computerized image capture system, 
followed by regeneration and modification using Adobe Photoshop Elements 5.0, USA. 
 
Fig.2 The schematic diagram of the procedures for measurement in human adrenal 
specimen. The left representative micrograph proceeded by immunohistochemistry for 
3βHSD was firstly drawn two straight lines signifying total thickness and ZR thickness 
respectively; then, these two lines were copied to the right micrograph of measurement scale 
so that their accurate lengths could be read (1200µm for the total thickness and 56oµm for ZR 
thickness). 
 
Fig.3 Age-related changes of total thickness in human adrenal cortex. Adrenal cortex 
thickness was studied in 25 male and 19 female adrenal glands from 0 to 20 years of age. 
Panel A. In male adrenals, the thickness in Group 0-3 years old was lower than the older 
groups which were not significantly different (* vs. Group 0-3 years old, p<0.05); Panel B. In 
female adrenals, the total thickness in Group 13-20 years old but not in 4-12 years old was 
significantly greater than that in 0-3 years old group (* vs. Group 0-3 years old, p<0.01). 
 
Fig.4 Age-related changes of ZR thickness. ZR thickness was studied in 25 male and 19 
female adrenal glands from 0 to 20 years of age. Before approximately 4 years old, the 
morphologically intact ZR could not be recognized in male or females. However, after 4 years 
old, the age-related continuous ZR development was demonstrated in male (panel A) and in 
female (panel C). The thickness in Group 13-20 years old was more significant than that in 
Group 4-12 years old in both male (Panel B) and female adrenals (Panel D) (* vs. Group 0-3 
years old, p<0.01; # vs. Group 4-12 years old, p<0.01). 
 
Fig.5 Age-related changes of the ratio of ZR thickness to that of total cortex. Since the 
initiation of ZR development, it showed the age-related increase in the thickness occupied by 
the ZR in total cortex in both male (panel A) and female adrenals (panel C). The value in 
Group 13-20 years old compared with 4-12 years old was significant in both male (Panel B) 
and female adrenals (Panel D) (* vs. Group 0-3yr, p<0.01; # vs. Group 4-12yr, p<0.01). 
 
Fig.6 Immunohistochemistry for Ki67 in male adrenals. Adrenal expression of Ki67 was 
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studied in 25 male adrenal glands from 0 to 20 years of age. As shown in these representative 
micrographs, immunoreactivity of Ki67 was predominantly detected in ZG around 8 months 
(panel A). Some individual positive cells could be observed in the ZR at 4 years old (panel B) 
and stronger immunoreactivity was detected in the ZR or the transitional area between ZF and 
ZR around 12 years old (panel C), but it is hard to detect the immunoreactivity in adrenal 
specimen near 20 years old (panel D). (Bar=10µm original magnification 100x)  
ZG, zona glomerulosa; ZF, zona fasciculata; ZR, zona reticularis; 
 
Fig.7 Immunohistochemistry for Ki67 in female adrenals. Adrenal expression of Ki67 was 
studied in 19 female adrenal glands from 0 to 20 years of age. As shown in these 
representative micrographs, immunoreactivity of Ki67 was mainly located in the ZG around 7 
months (panel A). The majority of positive cells appeared in ZF and also could be detected in 
ZR around 5 years old (panel B). A great number of positive cells aggregated in ZR or the 
transition between ZF and ZR around 15 years old (panel C), but few adrenal cortical cells 
could be detected in adrenal specimen near 20 years old (panel D). (Bar=10µm original 
magnification 100x)   ZG, zona glomerulosa; ZF, zona fasciculata; ZR, zona reticularis; 
 
Fig.8 Immunohistochemistry for Bcl-2 in human young adrenals. Adrenal expression of 
Bcl-2 was studied in 44 adrenal glands from 0 to 20 years of age. As shown in these 
representative micrographs, the immunoreactivity of Bcl-2 in male adrenals was 
predominantly detected in the outer ZF before the appearance of ZR around 3 years old (panel 
A); The expression of Bcl-2 could be discernible in ZR while it was also observed in the outer 
ZF around 9 years old (panel B), followed by increase of immunoreactivity in ZR and gradual 
decrease in the inner ZF near 20 years old (panel C). In female adrenals, the immunoreactivity 
showed the similar characteristics to male specimens displayed by panel D (age 3 years old), 
E (age 8 years old) and F (age 16 years old). (Bar=25µm original magnification 40x)  
ZG, zona glomerulosa; ZF, zona fasciculata; ZR, zona reticularis; M, medulla. 
 
Fig.9 The comparison of immunoreactivity of Bcl-2 between ZF and ZR in human young 
adrenals. The higher level was demonstrated in the ZF in 4-12 years old but in the ZR in 
13-20 years old in both male (panel A, * vs. ZR; # vs. ZF, p<0.01) and female adrenals (panel 
B, * vs. ZR; # vs. ZF, p<0.01). Besides, the inversed correlation of Bcl-2 immunoreactivity 
between ZR and ZF was demonstrated in both male (r=-0.827 p<0.01, panel C) and female 
adrenals (r=-0.595, p<0.05, panel D). 
 
Fig.10 Immunohistochemistry for HSD17B5 in human young adrenals. In male adrenals, 
the immunoreactivity of HSD17B5 was not detected in the cytoplasm of cortical cells in the 
ZR until around 9 years old, followed by progressive enlargement toward 20 years old. (panel 
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A, B, C, ages 4, 9, 19 years old, respectively). In female adrenals, negative expression was 
demonstrated around 5 years old (panel D), and became discernible in the cytoplasm of ZR 
cells around 9 years old and became stronger around 16 years old (panel E and F). 
(Bar=25µm original magnification 40x)   
ZG, zona glomerulosa; ZF, zona fasciculata; ZR, zona reticularis; M, medulla. 
 
Fig.11 Analysis of correlation between the established ZR thickness and the HSD17B5 
immunoreactive ZR thickness in the human adrenals. The positive correlation was 
demonstrated in both male (panel A, r=0.991, p<0.01) and female adrenals (panel B, r=0.989, 
p<0.01). 
 
Fig.12 Diagrammatic representation of the plasma concentration of DHEAS over the 
lifer span in human. Before birth, (A) the fetal zone secretes plenty of DHEA-S, following 
birth (B), the fetal zone rapidly involutes (C). By about 6 or 7 years old, ZR cells begin to rise 
(Adrenarche) (D). The achievement of the peak concentration in young adulthood (E) is 
followed by a progressive decline in the level of DHEA-S so that DHEA-S concentration is 
often very low by age 70 years and beyond (F). The ordinate represents concentration of 
DHEAS; the abscissa represents age in years; the scale is expanded before 10 years old. 
 
Fig.13 Correlation between the development of the adrenal and the increase in plasma 
DHEAS level. It was shown that the thickness of the ZR (expressed by % of subjects with 
continuous zona reticularis) corresponds to the increased production of DHEAS. This figure is 
quoted from the original publications by Dhom and Reiter (Ref. 9, 33). 
 
Fig.14 Schematic description of ZR development. (H&E staining, original magnification 
40x) The fetal adrenal cortex consists of definitive (D) and fetal zones (F) (Panel A). The fetal 
zone involutes and the definitive cells differentiate into the postnatal ZG and ZF, with the 
appearance of medullar capsule between the cortex and medulla at the end of 1 year old 
(Panel B, arrow). Around 3 years old, the dissolution of medullar capsule could be seen 
without the onset of intact ZR (Panel C). The discernible intact ZR develops in the innermost 
cortex around 4 years old (Panel D, see arrowhead).  
ZG, zona glomerulosa; ZF, zona fasciculata; ZR, zona reticularis; M, medulla 
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